Document is current
Any future updates will be listed below
-
Authors
Harris, Meredith G.
Kazdin, Alan E.
Munthali, Richard J.
Vigo, Daniel V.
Stein, Dan J.
Viana, Maria Carmen
Aguilar-Gaxiola, Sergio
Al-Hamzawi, Ali
Alonso, Jordi
Andrade, Laura Helena
Bunting, Brendan
Chardoul, Stephanie
Gureje, Oye
Hu, Chiyi
Hwang, Irving
Karam, Elie G.
Navarro-Mateu, Fernando
Nishi, Daisuke
Orozco, Ricardo
Sampson, Nancy A.
Scott, Kate M.
Vladescu, Cristian
Wojtyniak, Bogdan
Xavier, Miguel
Zarkov, Zahari
Kessler, Ronald C.
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R01 MH070884)
John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, & R01 DA016558)
Fogarty International Center (FIRCA R03-TW006481)
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 7 February 2024
First Online: 1 March 2024
Declarations
:
: At all survey sites, the local ethics or institutional review committee reviewed and approved the protocol to ensure protection of human subjects, in line with appropriate international and local guidelines. Details of the ethics committees for the WMH surveys can be viewed at this link: .
: Not applicable.
: DJS reports personal fees from Discovery Vitality, Johnson & Johnson, Kanna, L’Oreal, Lundbeck, Orion, Sanofi, Servier, Takeda and Vistagen. In the past 3 years, RCK was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Holmusk, Partners Healthcare, Inc., RallyPoint Networks, Inc., and Sage Therapeutics. He has stock options in Cerebral Inc., Mirah, PYM, Roga Sciences and Verisense Health. All other authors report no competing interests.
